Consumers will be under pressure and there may be a cost of living crisis, hospital operator says
The outcome is a blow for African governments that had hoped to see newly established facilities used for more than just Covid-19
The group has another new set of financiers, which has given it an extra five months, as well as better terms, to repay the debt
Dissenting shareholders had been elected to the Ascendis’s board last week, raising the prospect of its current lenders calling in their debt
The battle for Boots is set to be a litmus test for dealmaking in the UK as credit markets become more fragile
The information includes first names and surnames, email addresses and cellphone numbers
Jorge Gomez’s former employer disclosed an internal investigation of financial reporting matters, says pharma firm
The election of three new board members poses a risk that its lenders will call in their debt
German biotech stands by lower forecast for Covid-19 vaccine orders
Mboweni served on Discovery’s board from 2013 to 2018, but left to become finance minister
Should Roe v. Wade be overturned, demand for safe, effective abortion pills will surge — but the US anti-abortion movement uses national and state laws to ...
The drugmaker says it has been has been let down by the lack of interest in its locally made version of Johnson & Johnson’s dose
US biotech company announces more deep cost cuts as it searches for successor
Private hospital operators recover with normalisation as Covid-19 cases fall
The drugmaker warns of delays in developing a new generation of MS treatment as patients in Ukraine in its clinical trials flee the war
Shares surge as much as 30% after the bid by consortium that includes KKR, pension fund Hesta and Abu Dhabi Investment Authority
Revenue in the hospital operator’s year to end-March was 4.8% higher than its largely pandemic-free 2020 year
Private hospital group has continued to grow its performance despite fewer patients with acute cases of Covid-19 being admitted to hospital
War is pushing up energy prices and putting pressure on high inflation rates in Europe, says manufacturer
The family has struck a deal worth $6bn with the dissenting states, says a mediator in Purdue’s bankruptcy case
